Literature DB >> 24193348

A 1-bp duplication in TGFB2 in three family members with a syndromic form of thoracic aortic aneurysm.

Ruth Leutermann1, Sara Sheikhzadeh2, Lars Brockstädt2, Meike Rybczynski2, Vanessa van Rahden1, Kerstin Kutsche1, Yskert von Kodolitsch2, Georg Rosenberger1.   

Abstract

A number of autosomal dominantly inherited disorders, such as Marfan syndrome (MFS) and Loeys-Dietz syndrome (LDS), are associated with predisposition to thoracic aortic aneurysms and dissections (TAADs). In the majority of cases, mutations in genes encoding components of the transforming growth factor-β (TGF-β) signaling pathway, such as FBN1, TGFBR1, TGFBR2 and SMAD3, underlie the disease. Recently, a familial syndromic form of TAAD with other clinical features that overlap the MFS-LDS spectrum has been described to be caused by heterozygous loss-of-function mutations in TGFB2, encoding the TGF-β2 ligand of TGF-β serine/threonine kinase receptors (TGFBRs). We analyzed the TGFB2 gene by sequencing in a cohort of 88 individuals with a Marfan-like phenotype and/or TAAD, who did not have mutations in known genes causing thoracic aortic disease. We identified the novel heterozygous c.1165dupA mutation in exon 7 of TGFB2 in three members of a family, a 51-year-old male, his brother and nephew with aortic aneurysms, cervical arterial tortuosity and/or skeletal abnormalities as well as craniofacial dysmorphisms. The 1-bp duplication causes a frameshift leading to a stable transcript with a premature stop codon after seven TGF-β2-unrelated amino acids (p.Ser389Lysfs*8). As the resulting protein is unlikely functional and by considering data from the literature, we support the notion that functional haploinsufficiency for TGF-β2 predisposes to thoracic aortic disease. Taken together, TGFB2 is a rarely mutated gene in patients with syndromic TAAD, and the clinical features of our TGFB2 mutation-positive individuals fit in the scheme of LDS, rather than MFS-related disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24193348      PMCID: PMC4060107          DOI: 10.1038/ejhg.2013.252

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  22 in total

1.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

Review 2.  Marfan syndrome: an update of genetics, medical and surgical management.

Authors:  Yskert von Kodolitsch; Peter N Robinson
Journal:  Heart       Date:  2007-06       Impact factor: 5.994

Review 3.  Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction.

Authors:  Dianna M Milewicz; Dong-Chuan Guo; Van Tran-Fadulu; Andrea L Lafont; Christina L Papke; Sakiko Inamoto; Carrie S Kwartler; Hariyadarshi Pannu
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

Review 4.  The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision?

Authors:  Ana Luísa Silva; Luísa Romão
Journal:  FEBS Lett       Date:  2009-01-20       Impact factor: 4.124

5.  Conditional inactivation of TGF-β type II receptor in smooth muscle cells and epicardium causes lethal aortic and cardiac defects.

Authors:  Dominique Langlois; Mohammad Hneino; Lamia Bouazza; Ara Parlakian; Takako Sasaki; Giampiero Bricca; Jacques Yuan Li
Journal:  Transgenic Res       Date:  2010-03-06       Impact factor: 2.788

6.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

7.  Betaglycan presents ligand to the TGF beta signaling receptor.

Authors:  F López-Casillas; J L Wrana; J Massagué
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  Heterozygous TGFBR2 mutations in Marfan syndrome.

Authors:  Takeshi Mizuguchi; Gwenaëlle Collod-Beroud; Takushi Akiyama; Marianne Abifadel; Naoki Harada; Takayuki Morisaki; Delphine Allard; Mathilde Varret; Mireille Claustres; Hiroko Morisaki; Makoto Ihara; Akira Kinoshita; Koh-ichiro Yoshiura; Claudine Junien; Tadashi Kajii; Guillaume Jondeau; Tohru Ohta; Tatsuya Kishino; Yoichi Furukawa; Yusuke Nakamura; Norio Niikawa; Catherine Boileau; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2004-07-04       Impact factor: 38.330

9.  Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.

Authors:  Delphine Gomez; Ayman Al Haj Zen; Luciano F Borges; Monique Philippe; Paulo Sampaio Gutierrez; Guillaume Jondeau; Jean-Baptiste Michel; Roger Vranckx
Journal:  J Pathol       Date:  2009-05       Impact factor: 7.996

10.  Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.

Authors:  C Rodriguez; F Chen; R A Weinberg; H F Lodish
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

View more
  4 in total

1.  Total serum transforming growth factor-β1 is elevated in the entire spectrum of genetic aortic syndromes.

Authors:  Mathias Hillebrand; Nathalie Millot; Sara Sheikhzadeh; Meike Rybczynski; Sabine Gerth; Tilo Kölbel; Britta Keyser; Kerstin Kutsche; Peter N Robinson; Jürgen Berger; Thomas S Mir; Tanja Zeller; Stefan Blankenberg; Yskert von Kodolitsch; Britta Goldmann
Journal:  Clin Cardiol       Date:  2014-08-11       Impact factor: 2.882

2.  A missense TGFB2 variant p.(Arg320Cys) causes a paradoxical and striking increase in aortic TGFB1/2 expression.

Authors:  Raya Al Maskari; S Cleary; Nikki Figg; Sarju Mehta; Doris Rassl; Ian Wilkinson; Kevin M O'Shaughnessy
Journal:  Eur J Hum Genet       Date:  2016-10-26       Impact factor: 4.246

3.  Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation.

Authors:  Marco Ritelli; Nicola Chiarelli; Chiara Dordoni; Stefano Quinzani; Marina Venturini; Roberto Maroldi; Piergiacomo Calzavara-Pinton; Marina Colombi
Journal:  BMC Med Genet       Date:  2014-08-28       Impact factor: 2.103

4.  A mutation update on the LDS-associated genes TGFB2/3 and SMAD2/3.

Authors:  Dorien Schepers; Giada Tortora; Hiroko Morisaki; Gretchen MacCarrick; Mark Lindsay; David Liang; Sarju G Mehta; Jennifer Hague; Judith Verhagen; Ingrid van de Laar; Marja Wessels; Yvonne Detisch; Mieke van Haelst; Annette Baas; Klaske Lichtenbelt; Kees Braun; Denise van der Linde; Jolien Roos-Hesselink; George McGillivray; Josephina Meester; Isabelle Maystadt; Paul Coucke; Elie El-Khoury; Sandhya Parkash; Birgitte Diness; Lotte Risom; Ingrid Scurr; Yvonne Hilhorst-Hofstee; Takayuki Morisaki; Julie Richer; Julie Désir; Marlies Kempers; Andrea L Rideout; Gabrielle Horne; Chris Bennett; Elisa Rahikkala; Geert Vandeweyer; Maaike Alaerts; Aline Verstraeten; Hal Dietz; Lut Van Laer; Bart Loeys
Journal:  Hum Mutat       Date:  2018-03-06       Impact factor: 4.878

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.